FBNC Stock First Ban (FBNC, $48.45) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 18, 2025

GET DAILY SIGNALS

Get AI intraday signals

FBNC - First Bancorp

MACD signal

View

Odds of DOWN Trend

Price: $48.45

Daily change: +$0.26 (+0.54%)

Daily volume: 181.8K

Capitalization: $2B

Industry: Regional Banks

This is a Bearish indicator signaling FBNC's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 56 similar cases where FBNC's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

FBNC in downward trend: price may decline as a result of having broken its higher Bollinger Band on November 05, 2025

FBNC broke above its upper Bollinger Band on November 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 39 similar instances where the stock broke above the upper band. In of the 39 cases the stock fell afterwards. This puts the odds of success at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBNC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 25, 2025. You may want to consider a long position or call options on FBNC as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FBNC just turned positive on November 21, 2025. Looking at past instances where FBNC's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

FBNC moved above its 50-day moving average on November 25, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FBNC advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 181 cases where FBNC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 51, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FBNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.337) is normal, around the industry mean (1.127). P/E Ratio (21.727) is within average values for comparable stocks, (18.328). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.224). Dividend Yield (0.017) settles around the average of (0.036) among similar stocks. P/S Ratio (5.855) is also within normal values, averaging (5.231).